Zephyr AI

Zephyr AI is a precision medicine platform delivering actionable, biologically interpretable insights across the therapeutic lifecycle—from discovery to clinical deployment. Our software-native, AI-enabled modules predict drug response and reconstruct gene expression signatures from clinically available DNA-based inputs and drug metadata, and can be fine-tuned to novel therapeutics or diagnostics to streamline patient selection, inform trial design, and de-risk drug development within existing assay workflows. We turn fragmented, heterogeneous oncology data into patient-impacting decisions at scale. 

www.zephyrai.bio

Zephyr AI - 2026 Partner - 16th Clinical Biomarkers & CDx Summit
Zephyr AI - 2026 Partner - 16th Clinical Biomarkers & CDx Summit